Mutz Christopher Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$985,680.00

Insider Activity of Mutz Christopher

According to the SEC Form 4 filings, Mutz Christopher, being in a position of

  1. HEAD OF RARE DISEASE at ANI Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 21657 shares for $1.64M,
    over all time since 2023-11-10, has bought 0 shares, and sold 42157 shares for $2.86M.

Biography of Mutz Christopher

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,635,6016100

Comparison of Insiders on Amount of Buys and Sells

2026-03-13SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF RARE DISEASE
3,162
0.0143%
$71.64$226,526+10.57%
2026-03-09SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF RARE DISEASE
3,602
0.0161%
$74.18$267,196+3.84%
2026-03-06SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF RARE DISEASE
2,121
0.0095%
$74.22$157,421+4.88%
2026-03-02SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF RARE DISEASE
417
0.0019%
$74.00$30,858+2.79%
2026-02-20SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF RARE DISEASE
5,323
0.0238%
$78.02$415,300-1.12%
2026-02-12SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF RARE DISEASE
7,032
0.0313%
$76.55$538,300+0.73%
2025-05-14SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF RARE DISEASE
4,000
0.0185%
$60.45$241,800+32.75%
2024-11-15SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF RARE DISEASE
6,500
0.0304%
$57.70$375,050+15.32%
2024-05-21SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF RARE DISEASE
2,000
0.0095%
$61.61$123,220-2.61%
2024-03-05SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF RARE DISEASE
5,000
0.0246%
$66.00$330,000-7.61%
2023-11-10SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF RARE DISEASE
3,000
0.0149%
$52.47$157,410+15.67%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.